117 related articles for article (PubMed ID: 23835004)
1. Denosumab and atypical femur fractures.
Cating-Cabral MT; Clarke BL
Maturitas; 2013 Sep; 76(1):1-2. PubMed ID: 23835004
[No Abstract] [Full Text] [Related]
2. Denosumab and atypical femoral fractures.
Aspenberg P
Acta Orthop; 2014 Feb; 85(1):1. PubMed ID: 24171676
[No Abstract] [Full Text] [Related]
3. Atypical fracture of the femur in a patient using denosumab--a case report.
Schilcher J; Aspenberg P
Acta Orthop; 2014 Feb; 85(1):6-7. PubMed ID: 24460109
[No Abstract] [Full Text] [Related]
4. Atypical femoral fractures bilaterally in a patient receiving denosumab.
Drampalos E; Skarpas G; Barbounakis N; Michos I
Acta Orthop; 2014 Feb; 85(1):3-5. PubMed ID: 24171686
[No Abstract] [Full Text] [Related]
5. To treat osteoporosis, Denosumab appears more effective than Zoledronate. Denosumab has the advantage in building bone density, and has fewer side effects.
Duke Med Health News; 2014 Mar; 20(3):1-2. PubMed ID: 24683617
[No Abstract] [Full Text] [Related]
6. [Possible denosumab-induced jaw osteonecrosis in the treatment of osteoporosis. A case report].
Selvi Sabater P; Rizo Cerdá AM; Titos Arcos JC; Espuny Miró A
Farm Hosp; 2014 May; 38(3):248-9. PubMed ID: 24951910
[TBL] [Abstract][Full Text] [Related]
7. Bilateral atypical femoral fractures in a patient prescribed denosumab - a case report.
Thompson RN; Armstrong CL; Heyburn G
Bone; 2014 Apr; 61():44-7. PubMed ID: 24389366
[TBL] [Abstract][Full Text] [Related]
8. Denosumab is an option for treatment of osteoporosis.
Simonelli C
Am Fam Physician; 2012 Dec; 86(11):992; author reply 994. PubMed ID: 23198660
[No Abstract] [Full Text] [Related]
9. Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis.
Josse R; Khan A; Ngui D; Shapiro M
Curr Med Res Opin; 2013 Mar; 29(3):205-16. PubMed ID: 23297819
[TBL] [Abstract][Full Text] [Related]
10. Atypical diaphyseal femur fractures in patients with prolonged administration of bisphosphonate medication for osteoporosis.
Horning JA; Czajka J; Uhl RL
Orthopedics; 2010 Dec; 33(12):902. PubMed ID: 21117565
[No Abstract] [Full Text] [Related]
11. [Denosumab--a new efficient osteoporosis therapy].
Rejnmark L; Vestergaard P; Mosekilde L
Ugeskr Laeger; 2011 Jan; 173(5):346-9. PubMed ID: 21276398
[TBL] [Abstract][Full Text] [Related]
12. Atypical Femoral Fractures: A Teaching Perspective.
Khan AA; Leslie WD; Lentle B; Iles S; Kaiser SM; Frame H; Burrell S; Cheung AM
Can Assoc Radiol J; 2015 May; 66(2):102-7. PubMed ID: 25051904
[TBL] [Abstract][Full Text] [Related]
13. [Symptomatic hypocalcaemia on denosumab use].
Baptista Lopes V; Robbrecht D; van Thiel S; van Guldener C
Ned Tijdschr Geneeskd; 2013; 157(29):A6159. PubMed ID: 23859106
[TBL] [Abstract][Full Text] [Related]
14. Atypical femoral fractures and their relation to bisphosphonate use.
Tripto-Shkolnik L
Isr Med Assoc J; 2013 Aug; 15(8):447-50. PubMed ID: 24079069
[No Abstract] [Full Text] [Related]
15. [ASBMR 2010 report. Meeting report on the ASBMR. Obstacles in medicine for osteoporosis].
Koike T
Clin Calcium; 2011 Jan; 21(1):104-8. PubMed ID: 21187601
[TBL] [Abstract][Full Text] [Related]
16. Multiple ipsilateral femoral stress fractures in a patient taking denosumab for osteoporosis-a case report.
Piponov HI; Goldstein JM; Eisenberg GM
Osteoporos Int; 2020 Nov; 31(11):2263-2267. PubMed ID: 32561954
[TBL] [Abstract][Full Text] [Related]
17. [Is SSBT associated with atypical femoral fracture? SSBT is associated with atypical femoral fracture - pathophysiology of atypical femoral fractures - ].
Mashiba T
Clin Calcium; 2012 Jun; 22(6):914-8. PubMed ID: 22653033
[TBL] [Abstract][Full Text] [Related]
18. [Should we treat thalassemia-induced osteoporosis: two case reports].
Lucini M; Stoll D; Aubry-Rozier B; Lamy O
Praxis (Bern 1994); 2012 Oct; 101(20):1325-9. PubMed ID: 23032499
[TBL] [Abstract][Full Text] [Related]
19. Denosumab, osteoporosis, and prevention of fractures.
Kiechl S; Willeit J; Schett G
N Engl J Med; 2009 Nov; 361(22):2188-9; author reply 2190-1. PubMed ID: 19940304
[No Abstract] [Full Text] [Related]
20. Denosumab (prolia) for treatment of postmenopausal osteoporosis.
Johnson GL
Am Fam Physician; 2012 Feb; 85(4):334-6. PubMed ID: 22335312
[No Abstract] [Full Text] [Related]
[Next] [New Search]
